DCAA Executive Compensation Calculation Rejected (Again)
Client Alert | less than 1 min read | 06.21.12
In Metron, Inc., decided on June 4 by the ASBCA, DCAA's flawed methodology for assessing the reasonableness of executive compensation paid by government contractors was rejected for the second time this year by the Board. The board found that Metron appropriately based its compensation decisions on data in a single survey that was most relevant to Metron's business, found that other survey data that DCAA relied on was not relevant to Metron's compensation costs, and rejected all of the "adjustments" that DCAA had made to the relevant survey data because the adjustments were based on speculation and assumptions that were not supported by factual evidence.
Insights
Client Alert | 5 min read | 03.30.26
The EU Pharma Package: The Transferable Exclusivity Voucher Compromise Proposal
In our third alert in this EU Pharma Package Series, we provided a detailed overview of the diverging positions of the European Commission, the European Parliament , and the Council of the European Union on the transferable exclusivity voucher (TEV) for priority antimicrobials.
Client Alert | 2 min read | 03.27.26
CMS Releases PY 2020 RADV Audit Methods and Instructions: Key Takeaways for Health Plans
Client Alert | 4 min read | 03.25.26
NAIC Intensifies AI Regulatory Focus: What Health Insurance Payors Need to Know
Client Alert | 11 min read | 03.25.26
White House National AI Policy Framework Calls for Preempting State Laws, Protecting Children
